Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DeepIntent is a healthcare advertising demand-side platform (DSP) founded in 2016, positioned for pharmaceutical companies, healthcare marketers, and advertising agencies. It emphasizes combining data science, media activation capabilities, and healthcare industry expertise to connect patients with healthcare providers in a privacy-safe way. Unlike general marketing or SEO tools, DeepIntent is more of an enterprise-grade programmatic advertising platform than software for keyword rankings, on-site optimization, or content SEO.
Based on the available text, DeepIntent’s core promise centers on four areas: precise reach, performance, compliance, and partnership. The platform aims to help customers go beyond ad impressions and measure metrics closer to business outcomes, such as awareness, prescription lift, and patient adherence. On the compliance side, it explicitly mentions privacy, brand safety, and HIPAA compliance, which are especially critical for healthcare and pharmaceutical advertising. In terms of scale, the website states that it works with 600+ leading brands, 10+ top global pharmaceutical companies, and 50+ agencies, with a 98% customer retention rate. However, the text does not specify its data sources, audience pool size, detailed channel coverage, or the boundaries of its algorithmic capabilities.
For pricing, the official site content does not disclose public plans, CPM/platform fees, minimum budgets, or contract terms. It only offers “Get a Demo” / “Request a demo,” suggesting a sales-led custom pricing model. For channels, the navigation mentions Capabilities and Channels, but the main text does not list specific supported advertising channels such as display, video, CTV, mobile, or healthcare media networks. Integration details are also missing, so it is unclear whether DeepIntent supports connections with CRM, CDP, measurement platforms, data clean rooms, or mainstream ad tech stacks.
DeepIntent’s strength lies in its vertical focus on the healthcare industry, making it suitable for advertising scenarios with strict regulation and high compliance requirements. Its customer base, partnerships with leading pharmaceutical companies, and 98% retention rate also provide strong credibility. The platform emphasizes “outcomes” rather than just impressions, which can be attractive for pharmaceutical brands evaluating marketing impact. The downside is limited public transparency: pricing, data sources, channels, and integrations are not detailed in the available text. For general B2B, cross-border ecommerce, or SEO teams, it is not a general-purpose growth tool.
DeepIntent is better suited to mid-to-large pharmaceutical companies, healthcare brand marketing teams, healthcare advertising agencies, and teams that need to reach patients or healthcare providers under strict compliance requirements. Access from mainland China, supported payment methods, and local invoice/contract support are not mentioned in the text, so their status should be considered unknown. If alternatives are needed, it can be compared with general DSPs such as The Trade Desk, Google Display & Video 360, and Amazon DSP, as well as healthcare advertising platforms such as PulsePoint, Doximity, and Swoop.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on deepintent.com official site.
deepintent.com is an United States ads provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach deepintent.com directly.